Birdwatch Archive

Birdwatch Note

2024-08-07 10:09:11 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

次世代mRNAワクチン(レプリコン)「コスタイベ筋注用」は海外(ベトナム)で第III相まで治験が行われており、本ポストにある「治験と製造を日本が請け負った」「日本人で実験」は明らかな虚偽であることに注意が必要です。 https://www.mhlw.go.jp/content/10906000/001266060.pdf 国内でも既に第III相まで治験が行われたうえで製造販売承認されており、今秋から始まる接種が「実験」であるかのような本ポストは誤りです。 https://www.meiji-seika-pharma.co.jp/pressrelease/2023/detail/pdf/231128_02.pdf

Written by FD9D634B5E3595FCEA06C5B5995C7396927425DD8E65E7994DC893F223D0F3FC
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1821108888806305928

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1821126433856745853
  • noteId - 1821126433856745853
  • participantId -
  • noteAuthorParticipantId - FD9D634B5E3595FCEA06C5B5995C7396927425DD8E65E7994DC893F223D0F3FC Participant Details
  • createdAtMillis - 1723025351381
  • tweetId - 1821108888806305928
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • 次世代mRNAワクチン(レプリコン)「コスタイベ筋注用」は海外(ベトナム)で第III相まで治験が行われており、本ポストにある「治験と製造を日本が請け負った」「日本人で実験」は明らかな虚偽であることに注意が必要です。 https://www.mhlw.go.jp/content/10906000/001266060.pdf 国内でも既に第III相まで治験が行われたうえで製造販売承認されており、今秋から始まる接種が「実験」であるかのような本ポストは誤りです。 https://www.meiji-seika-pharma.co.jp/pressrelease/2023/detail/pdf/231128_02.pdf

Note Ratings

rated at rated by
2024-08-24 06:11:01 -0500 Rating Details
2024-08-09 11:35:32 -0500 Rating Details
2024-08-09 01:46:30 -0500 Rating Details
2024-08-09 01:26:00 -0500 Rating Details
2024-08-08 23:24:52 -0500 Rating Details
2024-08-08 23:05:01 -0500 Rating Details
2024-08-08 22:59:36 -0500 Rating Details
2024-08-08 22:29:08 -0500 Rating Details
2024-08-08 22:19:46 -0500 Rating Details
2024-08-08 22:19:41 -0500 Rating Details
2024-08-08 21:50:34 -0500 Rating Details
2024-08-08 20:18:36 -0500 Rating Details
2024-08-08 20:18:05 -0500 Rating Details
2024-08-08 19:57:04 -0500 Rating Details
2024-08-08 19:12:43 -0500 Rating Details
2024-08-08 18:53:50 -0500 Rating Details
2024-08-08 16:53:34 -0500 Rating Details
2024-08-08 13:46:47 -0500 Rating Details
2024-08-08 13:20:56 -0500 Rating Details
2024-08-08 10:00:07 -0500 Rating Details
2024-08-08 09:32:29 -0500 Rating Details
2024-08-08 09:13:32 -0500 Rating Details
2024-08-08 07:29:58 -0500 Rating Details
2024-08-08 07:03:38 -0500 Rating Details
2024-08-08 05:01:37 -0500 Rating Details
2024-08-08 03:51:01 -0500 Rating Details
2024-08-08 03:00:21 -0500 Rating Details
2024-08-08 01:53:43 -0500 Rating Details
2024-08-07 23:59:12 -0500 Rating Details
2024-08-07 23:53:48 -0500 Rating Details
2024-08-07 23:36:51 -0500 Rating Details
2024-08-07 23:34:33 -0500 Rating Details
2024-08-07 23:08:57 -0500 Rating Details
2024-08-07 23:08:28 -0500 Rating Details
2024-08-07 23:00:30 -0500 Rating Details
2024-08-07 22:45:56 -0500 Rating Details
2024-08-07 22:29:47 -0500 Rating Details
2024-08-07 22:17:26 -0500 Rating Details
2024-08-07 22:12:54 -0500 Rating Details
2024-08-07 21:20:19 -0500 Rating Details
2024-08-07 21:10:42 -0500 Rating Details
2024-08-07 18:26:19 -0500 Rating Details
2024-08-07 14:56:28 -0500 Rating Details
2024-08-07 11:44:12 -0500 Rating Details
2024-08-07 11:25:56 -0500 Rating Details
2024-08-07 09:36:42 -0500 Rating Details
2024-08-07 08:27:53 -0500 Rating Details
2024-08-07 08:17:50 -0500 Rating Details
2024-08-07 08:17:01 -0500 Rating Details
2024-08-07 07:57:26 -0500 Rating Details
2024-08-07 07:55:14 -0500 Rating Details
2024-08-07 07:49:49 -0500 Rating Details
2024-08-07 07:45:03 -0500 Rating Details
2024-08-07 07:44:28 -0500 Rating Details
2024-08-07 07:41:21 -0500 Rating Details
2024-08-07 07:41:16 -0500 Rating Details
2024-08-07 07:40:58 -0500 Rating Details
2024-08-07 07:23:52 -0500 Rating Details
2024-08-07 07:15:36 -0500 Rating Details
2024-08-07 07:12:38 -0500 Rating Details
2024-08-07 07:07:45 -0500 Rating Details
2024-08-07 07:06:33 -0500 Rating Details
2024-08-07 07:06:03 -0500 Rating Details
2024-08-07 07:01:01 -0500 Rating Details
2024-08-07 06:58:02 -0500 Rating Details
2024-08-07 06:49:12 -0500 Rating Details
2024-08-07 06:48:56 -0500 Rating Details
2024-08-07 06:44:26 -0500 Rating Details
2024-08-07 06:38:02 -0500 Rating Details
2024-08-07 06:30:50 -0500 Rating Details
2024-08-07 06:21:09 -0500 Rating Details
2024-08-07 06:11:53 -0500 Rating Details
2024-08-07 06:01:09 -0500 Rating Details
2024-08-07 05:54:26 -0500 Rating Details
2024-08-07 05:52:05 -0500 Rating Details
2024-08-07 05:51:26 -0500 Rating Details
2024-08-07 05:46:37 -0500 Rating Details
2024-08-07 05:40:29 -0500 Rating Details
2024-08-07 05:35:30 -0500 Rating Details
2024-08-07 05:28:23 -0500 Rating Details
2024-08-07 05:28:17 -0500 Rating Details
2024-08-07 05:25:25 -0500 Rating Details
2024-08-07 05:24:49 -0500 Rating Details
2024-08-07 05:21:59 -0500 Rating Details
2024-08-07 05:20:26 -0500 Rating Details
2024-08-07 05:18:20 -0500 Rating Details
2024-08-07 05:16:28 -0500 Rating Details
2024-08-08 18:21:39 -0500 Rating Details
2024-08-08 07:54:33 -0500 Rating Details
2024-08-08 03:12:36 -0500 Rating Details
2024-08-08 00:58:46 -0500 Rating Details
2024-08-07 22:58:54 -0500 Rating Details
2024-08-07 22:18:36 -0500 Rating Details
2024-08-07 21:22:57 -0500 Rating Details
2024-08-07 21:13:07 -0500 Rating Details
2024-08-07 16:58:40 -0500 Rating Details
2024-08-07 09:50:22 -0500 Rating Details
2024-08-07 09:20:00 -0500 Rating Details
2024-08-07 09:15:11 -0500 Rating Details
2024-08-07 08:57:47 -0500 Rating Details
2024-08-07 08:26:26 -0500 Rating Details
2024-08-07 07:52:36 -0500 Rating Details
2024-08-07 07:04:54 -0500 Rating Details
2024-08-07 06:33:09 -0500 Rating Details
2024-08-07 06:12:27 -0500 Rating Details
2024-08-07 06:05:54 -0500 Rating Details
2024-08-07 05:57:46 -0500 Rating Details
2024-08-07 05:44:07 -0500 Rating Details
2024-08-07 05:24:35 -0500 Rating Details
2024-08-07 05:23:48 -0500 Rating Details
2024-08-30 03:15:52 -0500 Rating Details
2024-10-03 17:12:23 -0500 Rating Details